The Michigan State University Board of Trustees today approved construction of a $335 million biomedical research center near the intersection of Amsterdam Avenue and Detroit Third Avenue.
The seven-story, 335,000-square-foot facility will be owned and co-operated by Michigan State University, the result of a 30-year partnership with Henry Ford Health.
The Henry Ford Health + Michigan State University Research Center will be MSU's largest research facility to date, designed to house more than 80 principal investigator teams and the latest technology.
Detroit's new Henry Ford Health + Michigan State University Health Sciences Research Center is scheduled to open in 2027 near the intersection of Amsterdam Avenue and Third Avenue in Detroit. This is a rendering of the north entrance courtesy of ZGF Architects LLP.
The center is part of the $3 billion Future of Health development with Henry Ford, MSU and the Detroit Pistons, which includes a new hospital tower and campus and mixed-use/mixed-income residential buildings. There is.
“MSU has a long history of work in Detroit, and our partnership with Henry Ford Health allows us to have an even greater impact on the health of people in our city and across the state,” said MSU President Kevin.・Dr. M. Guskiewicz said. “As Spartans, working together to advance the common good is in our DNA, and we are committed to working with our partners to address health equity and other great challenges of our time. looking forward to it.”
For more than a century, Henry Ford Health has stood for clinical research expertise and the pursuit of cutting-edge treatments for patients. More than 130 of his researchers from the hospital system recently joined Michigan State University's faculty.
In 2022, Henry Ford Health + Michigan State University achieved Collaborative Research Institution designation by the National Institutes of Health.
The seven-story, 335,000-square-foot Henry Ford Health + Michigan State University Health Sciences Research Center in Detroit will enable partners to expand research in areas such as cancer, neuroscience, immunology and public health. Rendering of the east entrance courtesy of ZGF Architects LLP.
“This unique partnership between an integrated academic health system and MSU will expand the reach of health care in the city, state and other regions,” said Bob Riney, president and CEO of Henry Ford Health. It will force us to restructure and rethink how we do business.” “We are advancing collaboration and discovery in ways that would not be possible as separate organizations. We anticipate continued transformational developments across the Detroit campus, which is why this research center is the first to break ground on the new campus.” I’m proud of that.”
This new facility will enable partners to expand their research in areas such as cancer, neuroscience, immunology and public health. There will be a focus on addressing health inequalities, disparities and social determinants of health.
“With the endorsement of Henry Ford Health + Michigan State University Research Center, we are setting the stage for a future where health care innovation, education and community engagement come together,” MSU Board of Trustees said. said Dan Kelly, chairman of the board. “This investment pushes the boundaries of medical knowledge and represents MSU’s commitment to advancing biomedical research and to the people of Detroit and the broader Michigan community.”
“MSU values a community-based approach that fosters discovery, innovation and, above all, partnership with our neighbors,” said Norman Beauchamp Jr., MSU Executive Vice President for Health Sciences. “Our goal is to build a research powerhouse focused on bringing hope and health to all people, and to be a national model for how universities, health systems, and communities can work together. .”
The Henry Ford Health + Michigan State University Research Center in Detroit will be MSU's largest research facility to date. Rendering provided by ZGF Architects LLP.
The Nick Gilbert Neurofibromatosis Institute, along with researchers from partner institutions, will occupy an entire floor of the building. This will be the first brick-and-mortar laboratory dedicated solely to neurofibromatosis, providing unique opportunities to collaborate with researchers from around the world across the partnership.
Construction of the research center is scheduled to begin in mid-May. The research center is scheduled to open in 2027.
